KTx-CONNECT digitizes the MAPS adherence workflow for pediatric kidney transplant programs — helping care teams identify patient-reported barriers, document a concrete plan, and follow up between visits.
The Medication Adherence Promotion System protocol is one of the few evidence-based approaches to adherence in pediatric transplantation. KTx-CONNECT digitizes it — turning each clinic visit into a structured assess-plan-follow-up cycle without adding burden to the care team.
Patients complete a clinically validated 14-item barriers assessment from a text link — no app, no account. Takes 60 seconds. Results reach the clinician before the patient walks in.
The clinician portal surfaces the patient's primary barrier and preferred strategies. The visit is focused before it begins — guided by the patient's own choices, not the clinician's assumptions.
Automated check-in texts go out 7 days after each visit. Patient responses flow back in real time. The dashboard surfaces who is struggling before the next appointment.
Four concrete steps that turn the MAPS protocol into a repeatable clinical process.
A secure, one-time link arrives by text. The patient selects applicable barriers from a validated 14-item list — including free-text entry for barriers that don't fit. Whatever is blocking them surfaces here, in their own words.
The clinician sees the patient's primary barrier, preferred strategies, and free-text entries the moment the assessment is submitted. The clinical workspace is ready before the patient arrives.
Using motivational interviewing, the team and patient land on one specific strategy — documented in the patient's own words with a single tap. A 7-day follow-up is automatically scheduled.
Seven days later the patient receives a text showing their own agreed plan. They rate how things are going and add an optional note. Patients who are struggling rise to the top of the dashboard automatically — no phone calls, no staff time.
Every design decision traces back to published clinical work. The protocol is validated. The outcomes are published. The infrastructure is new.
The Barriers Assessment Tool was designed for routine use in transplant workflows. It converts "nonadherence" into specific, actionable targets — in the patient's own voice.
In pediatric and young adult kidney transplant recipients, identified adherence barriers were associated with 2.6× higher subsequent rejection risk — supporting early, systematic detection.
Clinical implementation of MAPS-based adherence promotion was associated with meaningful reduction in rejection episodes in pediatric transplant recipients — with published outcomes data.
Structured adherence programs have been modeled as cost-saving — reinforcing the case for scalable, team-based approaches that more programs can sustain long term.
KTx-CONNECT is built by the same clinical research team that created, tested, and published outcomes data on MAPS — the Medication Adherence Promotion System. The protocol is not theoretical: it was developed in the clinic, validated in real patient populations, and published in peer-reviewed literature before a single line of platform code was written. The people building this tool are the same people who know, from direct clinical experience, what gets in the way of adherence and what actually works.
KTx-CONNECT is designed for healthcare implementation. Pilot deployments are structured with appropriate compliance, privacy, and data-use agreements in place before any patient use.
For transplant programs, innovation offices, QI teams, and research collaborators.
We're happy to walk through the platform, discuss fit for your program, or explore a pilot partnership.